Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects (Q34697810)

4 August 2017

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects (English)

1 reference

4 August 2017

1 reference

1 reference

Patricia Winokur

2

0 references

Robert B Belshe

4

object named as

Robert Belshe

1 reference

4 August 2017

Robert B Couch

1

1 reference

4 August 2017

Rebecca Brady

3

1 reference

4 August 2017

Wilbur H Chen

5

1 reference

4 August 2017

Thomas R Cate

6

1 reference

4 August 2017

Bryndis Sigurdardottir

7

1 reference

4 August 2017

Amy Hoeper

8

1 reference

4 August 2017

Irene L Graham

9

1 reference

4 August 2017

Robert Edelman

10

1 reference

4 August 2017

Fenhua He

11

1 reference

4 August 2017

Diane Nino

12

1 reference

4 August 2017

Jose Capellan

13

1 reference

4 August 2017

Frederick L Ruben

14

1 reference

4 August 2017

language of work or name

English

0 references

publication date

14 September 2007

1 reference

4 August 2017

1 reference

4 August 2017

25

1 reference

4 August 2017

7656-7663

1 reference

4 August 2017

44

1 reference

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

An overview of serum antibody responses to influenza virus antigens.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Immunity to influenza in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Purified influenza virus vaccine. A study of viral reactivity and antigenicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Antibody response in volunteers to Asian influenza vaccine

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on Antigenicity

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2243220

An outbreak of influenza A2 in a population with a known antibody profile

26 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.042

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.042

Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.042

10.1016/J.VACCINE.2007.08.042

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

4 August 2017

1 reference